Who are the providers of clonazepam's raw materials used by aurobindo?

I can’t reliably name (or “identify”) the specific raw‑material providers/vendors that Aurobindo uses for clonazepam based on general knowledge alone—those sourcing details are usually not publicly listed in a way that’s verifiable, and they can change over time.

What I can do is point you to the places where this information is typically found:

1. Regulatory filings for Aurobindo’s clonazepam

   • Check the drug’s Drug Master File (DMF) / API information, or the manufacturer/supplier of API listed in submissions.
   • Depending on the country (US/EU/India), the public assessment documents or labeling sometimes disclose the API manufacturer (not always the upstream raw-material supplier).

2. US FDA / EU databases

   • US: FDA’s Orange Book (product label/manufacturer) and sometimes associated API information via DMF-linked data.
   • EU: EMA EPARs/assessment reports (if applicable) or national competent authority sources.
   • These typically still won’t list the upstream raw-material contractor, but may identify the API manufacturer.

3. Quality / audit documents

   • Raw material suppliers can be identified only through quality agreements, supplier qualification lists, or inspection reports, which are not routinely public.

If you tell me which market/country you mean (e.g., US, EU, India) and ideally the strength/form (tablets, etc.) or a link/label to Aurobindo’s product, I can help you look up the publicly listed API manufacturer(s) and what’s actually disclosed—then we can narrow down as far as the public records allow.